Healthcare and Medical

home | healthcare and medical | company profile

£265.00
Alerts
Change Currency EuroUSDGBP

Indevus Pharmaceuticals - Premium Company Profile (Datamonitor)

  • Market: Healthcare and Medical
  • Published Date: 18/12/2007
  • Report Title: Indevus Pharmaceuticals - Premium Company Profile
  • Table of Contents: View Table of Contents
  • Report Type: Company Profile
  • Country: Global
  • Number of Pages: 58
Introduction

Indevus Pharmaceuticals is a biopharmaceutical company focused on obtaining product candidates and product from other pharmaceutical and biotechnology companies through collaboration, in licensing and acquisitions. The company's acquisition of Valera Pharmaceuticals in April 2007 has expanded its product portfolio, establishing it as an emerging leader in the areas of urology and men's health.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


  • Highlights

    Indevus Pharmaceuticals is a biopharmaceutical company engaged in the acquisition, development and commercialization of products to treat urological, gynecological and men's health conditions.

    The company's marketed products are: Sanctura for the treatment of overactive bladder; Delatestryl for treating hypogonadism in men; Supprelin-LA for the treatment of central precocious puberty; and Vantas indicated in hormone suppression therapy for advanced prostate cancer.

    Indevus Pharmaceuticals derives its revenues from contract and license fees and product revenues which include revenues from sales of products, commissions and royalties. The company obtains products and product candidates through acquisitions and licensing agreements with other pharmaceutical and biotechnology companies.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization
  • £265.00   Share Report
     
    Alerts  

    Purchase Information

    There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses Worldpay. Worldpay is part of The Royal Bank of Scotland Group, the 5th biggest banking group in the world. Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.

    Worldpay Logo
    Chancy Currency EUR USD GBP
    Customer Area
    English Italian Spanish French German Russian Chinese Arabic